| Primaquine hybrids as promising antimycobacterial and antimalarial agents K Pavić, I Perković, Š Pospíšilová, M Machado, D Fontinha, M Prudêncio, ... European journal of medicinal chemistry 143, 769-779, 2018 | 45 | 2018 |
| Novel urea and bis-urea primaquine derivatives with hydroxyphenyl or halogenphenyl substituents: Synthesis and biological evaluation I Perković, M Antunović, I Marijanović, K Pavić, K Ester, M Kralj, J Vlainić, ... European journal of medicinal chemistry 124, 622-636, 2016 | 38 | 2016 |
| Novel semicarbazides and ureas of primaquine with bulky aryl or hydroxyalkyl substituents: Synthesis, cytostatic and antioxidative activity K Pavić, I Perković, M Cindrić, M Pranjić, I Martin-Kleiner, M Kralj, ... European journal of medicinal chemistry 86, 502-514, 2014 | 36 | 2014 |
| Design, synthesis and biological evaluation of novel primaquine-cinnamic acid conjugates of the amide and acylsemicarbazide type K Pavić, I Perković, P Gilja, F Kozlina, K Ester, M Kralj, D Schols, ... Molecules 21 (12), 1629, 2016 | 30 | 2016 |
| Machine learning prioritizes synthesis of primaquine ureidoamides with high antimalarial activity and attenuated cytotoxicity J Levatić, K Pavić, I Perković, L Uzelac, K Ester, M Kralj, M Kaiser, ... European journal of medicinal chemistry 146, 651-667, 2018 | 16 | 2018 |
| Primaquine derivatives: Modifications of the terminal amino group B Zorc, I Perković, K Pavić, Z Rajić, M Beus European journal of medicinal chemistry 182, 111640, 2019 | 15 | 2019 |
| Insights into the mechanism of antiproliferative effects of primaquine-cinnamic acid conjugates on MCF-7 cells P Mabeta, K Pavić, B Zorc Acta Pharmaceutica 68 (3), 337-348, 2018 | 14 | 2018 |
| Insights into biological activity of ureidoamides with primaquine and amino acid moieties J Vlainić, I Kosalec, K Pavić, D Hadjipavlou-Litina, E Pontiki, B Zorc Journal of enzyme inhibition and medicinal chemistry 33 (1), 376-382, 2018 | 14 | 2018 |
| Synthesis and biological evaluation of harmirins, novel harmine–coumarin hybrids as potential anticancer agents K Pavić, M Beus, G Poje, L Uzelac, M Kralj, Z Rajić Molecules 26 (21), 6490, 2021 | 12 | 2021 |
| Chloroquine urea derivatives: synthesis and antitumor activity in vitro K Pavić, Z Rajić, Z Mlinarić, L Uzelac, M Kralj, B Zorc Acta Pharmaceutica 68 (4), 471-483, 2018 | 10 | 2018 |
| Harmicens, novel harmine and ferrocene hybrids: design, synthesis and biological activity G Poje, M Marinović, K Pavić, M Mioč, M Kralj, LP de Carvalho, J Held, ... International journal of molecular sciences 23 (16), 9315, 2022 | 9 | 2022 |
| Second generation of primaquine ureas and bis-ureas as potential antimycobacterial agents K Pavić, Z Rajić, H Michnová, J Jampílek, I Perković, B Zorc Molecular diversity 23, 657-667, 2019 | 8 | 2019 |
| Anthranilamides with quinoline and β-carboline scaffolds: Design, synthesis, and biological activity M Beus, L Persoons, D Daelemans, D Schols, K Savijoki, P Varmanen, ... Molecular diversity, 1-18, 2022 | 7 | 2022 |
| Primaquine homodimers as potential antiplasmodial and anticancer agents K Pavić, B Rubinić, Z Rajić, D Fontinha, M Prudêncio, L Uzelac, M Kralj, ... Bioorganic & medicinal chemistry letters 29 (19), 126614, 2019 | 4 | 2019 |
| Melatonin K Pavić, B Zorc Farmaceutski glasnik 69 (4), 249-265, 2013 | 3 | 2013 |
| Design, synthesis and antiplasmodial evaluation of new amide-, carbamate-, and ureido-type harmicines M Marinović, H Rimac, LP de Carvalho, C Rôla, S Santana, K Pavić, ... Bioorganic & medicinal chemistry 94, 117468, 2023 | 2 | 2023 |
| Synthesis, antiproliferative and antiplasmodial evaluation of new chloroquine and mefloquine-based harmiquins K Pavić, G Poje, LP De Carvalho, J Held, Z Rajić Acta Pharmaceutica 73 (4), 537-558, 2023 | 1 | 2023 |
| Cimetna kiselina i njeni derivati K Pavić, B Zorc Farmaceutski glasnik 74 (6), 415-428, 2018 | 1 | 2018 |
| Sinteza, karakterizacija i biološko djelovanje semikarbazida, urea i ureidoamida primakina K Pavić University of Zagreb. Faculty of Pharmacy and Biochemistry. Department of …, 2017 | 1 | 2017 |
| Antiplasmodial activity of harmirins–novel harmine–coumarin hybrids K Pavić, Z Rajić, LP de Carvalho, J Held 7th Congress of Pharmacy in North Macedonia with international participation …, 2022 | | 2022 |
Branka ZorcUniversity of Zagreb Faculty of Pharmacy and BiochemistryVerified email at pharma.hr
